Chikungunya Vaccine in Clinical Trial

News   Jun 07, 2017 | Original Story from NIAID

 
Clinical Trial of Vaccine for Chikungunya Virus Begins
 
 
 

RELATED ARTICLES

Medivir Outsources Compound Management to BioAscent

News

BioAscent is now managing 56,000 samples of Medivir's compound collection for their ongoing drug discovery activities.

READ MORE

Mouse Model of Human Immune System Inadequate for Stem Cell Studies

News

“Humanized” mice are used to study human immune responses, but they are inadequate for stem cell studies, say Stanford researchers. Optimized models are needed for clinical decision-making.

READ MORE

Dotmatics Announces Guest Speakers for 2017 UK User Group Meeting

News

Dotmatics event, 2017 UK User Group Meeting, consists of global and notable guest speakers discussing the innovative future in the diverse field of bioinformatics.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE